Edwin Jonathan Tucker - 10 Nov 2021 Form 4 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)

Reporting relationship: Chief Medical Officer
Issuer ticker: MIRM
Reported as of: 10 Nov 2021
Net transaction value: +$946
SEC form: 4
Accepted by SEC: 15 Nov 2021, 15:23:29 UTC
Prior SEC filing: 01 Oct 2021
Next SEC filing: 13 Jun 2023
Source filing: View source filing
Reporting owner signature: /s/ Jody Howe, Attorney-in-Fact

Key filing fact

Edwin Jonathan Tucker filed Form 4 for Mirum Pharmaceuticals, Inc. (MIRM) on 15 Nov 2021.

Key facts

This page summarizes Edwin Jonathan Tucker's Form 4 filing for Mirum Pharmaceuticals, Inc. (MIRM).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 15 Nov 2021, 15:23.

Change

Previous filing in this sequence was filed on 01 Oct 2021.
Current net transaction value: +$946.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MIRM transaction

Common Stock

Award

Transaction value: $946
Shares: +70
Change %: +0.15%
Price: $13.52
Shares after: 45,838
Date: 10 Nov 2021
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This Form 4 is being filed voluntarily to report the acquisition of 70 shares by the Reporting Person on November 10, 2021 pursuant to the Issuer's Employee Stock Purchase Plan.